Advagraf 5 mg prolonged-release hard capsules clinical trials

Personalized Use of Resources Study (PURE)

This study, PURE, looks at how different versions of a medicine called tacrolimus work in kidney transplant patients. It aims to see if a newer version can be given at a lower dose while still keeping the right amount of medicine in the body, potentially leading to fewer side effects and easier treatment.

A Phase II, Open-Label, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted from a Prograf® Based Immunosuppressive Regimen to a Tacrolimus Prolonged Release, Advagraf® Based Immunosuppressive Regimen, Including a Long-Term Follow Up